US2016058904A1PendingUtilityA1
Chitosan-based hemostatic textile
Est. expiryNov 25, 2029(~3.3 yrs left)· nominal 20-yr term from priority
A61L 15/42A61L 15/28A61L 24/08A61L 2/081A61L 26/0023A61L 2400/04A61L 33/08A61L 31/042A61L 2/20A61L 2/14A61L 24/0036
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A microfibrillar high molecular weight chitosan-based textile can be used as a hemostat. The chitosan has been treated in a nitrogen field by applying energy to ionize nitrogen in and around the chitosan textile. A single or multiple such treatments may be employed. For example, the chitosan textile may be irradiated under nitrogen using γ-irradiation, treated under a nitrogen plasma, or both.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of making a hemostatic textile material, comprising processing crab shells to obtain a high molecular weight chitosan having a molecular weight in a range about 600-800 kDa and a degree of deacetylation of about 75-88%, processing the high molecular weight chitosan into a textile comprising a network of chitosan fibers, and irradiating the high molecular weight chitosan textile under nitrogen using γ-irradiation.
2 . The method of claim 1 additionally comprising treating the chitosan textile under a nitrogen plasma.
3 . The method of claim 2 additionally comprising soaking the chitosan fibers in an alcohol prior to treating with γ-irradiation or plasma.
4 . The method of claim 1 additionally comprising packaging the fibrous high molecular weight chitosan textile in a nitrogen field and sealing the package so that the chitosan textile is sealed within a nitrogen environment prior to γ-irradiation, and wherein the chitosan textile remains sealed within the package during irradiation.
5 . The method of claim 4 additionally comprising treating the chitosan textile under a nitrogen plasma, wherein the chitosan textile remains sealed within the package during nitrogen plasma treatment.
6 . The method of claim 5 comprising packaging the chitosan textile in a dry condition.
7 . The method of claim 4 , wherein the packaging comprises metalized packaging.
8 . The method of claim 4 additionally comprising forming the hemostatic chitosan textile into a woven or nonwoven fabric prior to packaging the chitosan.
9 . The method of claim 4 additionally comprising treating the chitosan fibers with an acetic acid solution.
10 . The method of claim 9 , wherein the acetic acid is a glacial acetic acid so as to form an ammonium salt of chitosan.
11 . A method of making a textile hemostatic material, comprising providing a high molecular weight chitosan having a molecular weight of about 600-800 kDa and a degree of deacetylation chosen to facilitate formation of dry fibers, processing the high molecular weight chitosan into a fibrous textile, and treating the high molecular weight chitosan textile under a nitrogen plasma.
12 . The method of claim 11 , wherein the step of sterilizing the fibrous chitosan under nitrogen is configured to increase the concentration of amino groups on the chitosan fibers.
13 . The method of claim 11 , comprising treating the chitosan textile in a nitrogen plasma at ambient temperature
14 . The method of claim 11 , wherein the chitosan has a degree of deacetylation of about 75-88%.
15 . The method of claim 14 , wherein the chitosan has a degree of deacetylation of about 80-85%.
16 . The method of claim 14 , wherein the chitosan has a degree of deacetylation of about 85%.Join the waitlist — get patent alerts
Track US2016058904A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.